Pivalde...Today's edition of Endpoints News has an interesting (and annoying) article entitled " Lending a hand to a biotech in trouble, GSK drops $ 75M cash to add late-stage antibiotic to portfolio." No worries, we shouldn't be annoyed or jealous because The Fund or some other major pharma will soon be coming to our rescue, hopefully, with a substantially better deal for PBT2. We're ready for this whenever somebody steps up to the plate...
Ann: Proposed issue of securities - ATH, page-13
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $13.66K | 3.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 56887006 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125743867 | 28 |
View Market Depth
| Last trade - 12.10pm 29/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |